US
Companies
16 published profiles. Every profile shows the source of each fact.
Grouped by each company's most recent verified valuation. Companies whose sources publish no valuation are in none of these groups.
- 3M Co3M COlistedUS-DEMedical Devices$81.1B Public float · as of 2025-06-30CIK 66740
- AbbVie Inc.listedUS-DEPharmaceuticals$325B Public float · as of 2025-06-30CIK 1551152
- Abbott LaboratoriesABBOTT LABORATORIESlistedUS-ILPharmaceuticals$232B Public float · as of 2025-06-30CIK 1800
- Amgen IncAMGEN INClistedUS-DEPharmaceuticals$150B Public float · as of 2025-06-30CIK 318154
- Boston Scientific CorpBOSTON SCIENTIFIC CORPlistedUS-DEMedical Devices$159B Public float · as of 2025-06-30CIK 885725
- Bristol Myers Squibb CoBRISTOL MYERS SQUIBB COlistedUS-DEPharmaceuticals$94.2B Public float · as of 2025-06-30CIK 14272
- ELI LILLY & ColistedUS-INPharmaceuticals$808B Public float · as of 2025-06-30CIK 59478
- Gilead Sciences, Inc.GILEAD SCIENCES, INC.listedUS-DEPharmaceuticals$103B Public float · as of 2025-06-30CIK 882095
- HCA Healthcare, Inc.listedUSHospitals and Clinics$63.3B Public float · as of 2025-06-30CIK 860730
- Johnson & JohnsonJOHNSON & JOHNSONlistedUS-NJPharmaceuticals$367B Public float · as of 2025-06-29CIK 200406
- Merck & Co., Inc.listedUS-NJPharmaceuticals$198B Public float · as of 2025-06-30CIK 310158
- Moderna, Inc.listedUS-DEPharmaceuticals$9.9B Public float · as of 2025-06-30CIK 1682852
- Pfizer IncPFIZER INClistedUS-DEPharmaceuticals$138B Public float · as of 2025-06-29CIK 78003
- Regeneron Pharmaceuticals, Inc.REGENERON PHARMACEUTICALS, INC.listedUS-NYPharmaceuticals$54.8B Public float · as of 2025-06-30CIK 872589
- Stryker CorpSTRYKER CORPlistedUS-MIMedical Devices$144B Public float · as of 2025-06-30CIK 310764
- Vertex Pharmaceuticals Inc / MAVERTEX PHARMACEUTICALS INC / MAlistedUS-MAPharmaceuticals$113B Public float · as of 2025-06-30CIK 875320
| Company | Valuation | Jurisdiction | Industry | Status |
|---|---|---|---|---|
| 3M Co 3M CO | $81.1B | US-DE listed | Medical Devices | Unknown |
| AbbVie Inc. | $325B | US-DE listed | Pharmaceuticals | Unknown |
| Abbott Laboratories ABBOTT LABORATORIES | $232B | US-IL listed | Pharmaceuticals | Unknown |
| Amgen Inc AMGEN INC | $150B | US-DE listed | Pharmaceuticals | Unknown |
| Boston Scientific Corp BOSTON SCIENTIFIC CORP | $159B | US-DE listed | Medical Devices | Unknown |
| Bristol Myers Squibb Co BRISTOL MYERS SQUIBB CO | $94.2B | US-DE listed | Pharmaceuticals | Unknown |
| ELI LILLY & Co | $808B | US-IN listed | Pharmaceuticals | Unknown |
| Gilead Sciences, Inc. GILEAD SCIENCES, INC. | $103B | US-DE listed | Pharmaceuticals | Unknown |
| HCA Healthcare, Inc. | $63.3B | US listed | Hospitals and Clinics | Unknown |
| Johnson & Johnson JOHNSON & JOHNSON | $367B | US-NJ listed | Pharmaceuticals | Unknown |
| Merck & Co., Inc. | $198B | US-NJ listed | Pharmaceuticals | Unknown |
| Moderna, Inc. | $9.9B | US-DE listed | Pharmaceuticals | Unknown |
| Pfizer Inc PFIZER INC | $138B | US-DE listed | Pharmaceuticals | Unknown |
| Regeneron Pharmaceuticals, Inc. REGENERON PHARMACEUTICALS, INC. | $54.8B | US-NY listed | Pharmaceuticals | Unknown |
| Stryker Corp STRYKER CORP | $144B | US-MI listed | Medical Devices | Unknown |
| Vertex Pharmaceuticals Inc / MA VERTEX PHARMACEUTICALS INC / MA | $113B | US-MA listed | Pharmaceuticals | Unknown |